Published in Medical Letter on the CDC and FDA, April 29th, 2001
They reported their findings in the April 2001 issue of the journal Infection and Immunity.
"For several decades the Mycobacterium-bovis-derived bacillus Calmette-Guerin (BCG) has been the only widely used vaccine for tuberculosis and accumulating data from clinical trials and subsequent meta-analysis have tended to reveal its general ineffectiveness in adults," said J.V. Brooks and colleagues. "The mechanism underlying the gradual loss of effectiveness of BCG as the individual...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.